James Investment Research Inc Innoviva, Inc. Transaction History

James Investment Research Inc

$853 Million
Q3 2024

A detailed history of James Investment Research Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, James Investment Research Inc holds 65,348 shares of INVA stock, worth $1.14 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

65,348

Previous 65,348 -0.0%

Holding current value

$1.14 Million

Previous $1.07 Million 17.74%

% of portfolio

0.15%

Previous 0.13%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$14.4 - $16.4 $122,918 - $139,990	8,536 Added 15.02%	65,348 $1.07 Million
Q1 2024 May 01, 2024	SELL	$14.56 - $16.78 $291,200 - $335,600	-20,000 Reduced 26.04%	56,812 $865,000
Q2 2023 Aug 07, 2023	BUY	$11.39 - $13.72 $874,888 - $1.05 Million	76,812 New	76,812 $977,000
Q1 2023 Apr 25, 2023	SELL	$10.73 - $13.6 $31,202 - $39,548	-2,908 Reduced 3.65%	76,812 $864,000
Q4 2022 Jan 30, 2023	BUY	$11.8 - $13.78 $147,240 - $171,946	12,478 Added 18.56%	79,720 $1.06 Million
Q3 2022 Oct 31, 2022	SELL	$11.61 - $15.22 $257,591 - $337,686	-22,187 Reduced 24.81%	67,242 $781,000
Q2 2022 Aug 01, 2022	BUY	$14.32 - $19.88 $127,390 - $176,852	8,896 Added 11.05%	89,429 $1.32 Million
Q1 2022 Apr 22, 2022	BUY	$15.39 - $20.25 $1,400 - $1,842	91 Added 0.11%	80,533 $1.56 Million
Q4 2021 Jan 28, 2022	BUY	$15.91 - $18.72 $159,100 - $187,200	10,000 Added 14.2%	80,442 $1.39 Million
Q2 2021 Jul 26, 2021	BUY	$11.45 - $13.96 $106,599 - $129,967	9,310 Added 15.23%	70,442 $945,000
Q1 2021 Apr 22, 2021	SELL	$11.06 - $12.87 $227,813 - $265,096	-20,598 Reduced 25.2%	61,132 $730,000
Q4 2020 Jan 27, 2021	SELL	$9.33 - $12.48 $201,164 - $269,081	-21,561 Reduced 20.87%	81,730 $1.01 Million
Q3 2020 Oct 23, 2020	SELL	$10.33 - $14.49 $246,391 - $345,615	-23,852 Reduced 18.76%	103,291 $1.08 Million
Q2 2020 Jul 24, 2020	BUY	$11.49 - $15.26 $102,869 - $136,622	8,953 Added 7.58%	127,143 $1.78 Million
Q1 2020 Apr 22, 2020	SELL	$8.11 - $15.23 $1.26 Million - $2.37 Million	-155,727 Reduced 56.85%	118,190 $1.39 Million
Q4 2019 Jan 24, 2020	BUY	$10.28 - $14.38 $1.88 Million - $2.64 Million	183,248 Added 202.11%	273,917 $3.88 Million
Q3 2019 Oct 30, 2019	SELL	$10.05 - $14.55 $154,820 - $224,142	-15,405 Reduced 14.52%	90,669 $955,000
Q2 2019 Jul 24, 2019	SELL	$13.1 - $14.95 $200,888 - $229,258	-15,335 Reduced 12.63%	106,074 $1.55 Million
Q1 2019 Apr 26, 2019	SELL	$13.69 - $20.06 $571,831 - $837,906	-41,770 Reduced 25.6%	121,409 $1.7 Million
Q4 2018 Jan 22, 2019	BUY	$13.96 - $18.26 $1.31 Million - $1.71 Million	93,659 Added 134.72%	163,179 $2.85 Million
Q3 2018 Oct 26, 2018	SELL	$13.63 - $15.7 $1.82 Million - $2.09 Million	-133,170 Reduced 65.7%	69,520 $1.06 Million
Q2 2018 Jul 19, 2018	BUY	$13.44 - $17.59 $2.72 Million - $3.57 Million	202,690 New	202,690 $2.8 Million
Q4 2017 Jan 23, 2018	SELL	$11.73 - $14.75 $2.46 Million - $3.09 Million	-209,620 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$12.06 - $14.12 $2.53 Million - $2.96 Million	209,620	209,620 $2.96 Million

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.21B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Account

James Investment Research Inc Innoviva, Inc. Transaction History